reports
Kanabo Launches eCommerce Platform to Help Improve Wellbeing of Millio...
LONDON--(BUSINESS WIRE)-- Kanabo, the UK medicinal cannabis company focusing on the development and distribution of cannabis-derived products for medical patients, is launching its eCommerce platform for wellness CBD consumers. The Kanabo.store will cater to the UK market initially and then roll out across Europe, giving CBD consumers access to Kanabo’s three proprietary CBD formula pods that work with Kanabo’s unique VapePod, the first of its kind medical grade vaporiser that provides easy-to-use metered dosing. Relax helps you quiet your mind and find your inner tranquility with a calming ...
Kanabo Upgrades CBD Manufacturing to EU GMP, Partners with Pure Origin...
LONDON--(BUSINESS WIRE)-- London, UK based medical cannabis R&D company, Kanabo Group Plc, has partnered with Pure Origin Ltd., a leader in best practices for EU GMP manufacturing. Good Manufacturing Practices (GMPs) are systems created and authorised by the government to regulate production, verification and validation of drugs, food and/or medical devices, ensuring that finished products are effective and safe for market distribution. Under the agreement Pure Origin will manufacture, package and supply Kanabo’s CBD wellness product line from their EU GMP manufacturing facility in Wales. The...
Kanabo Strengthens Operations Team, Welcoming Michal Ben Moshe as Gene...
LONDON--(BUSINESS WIRE)-- Kanabo Group Plc is thrilled to announce the new appointment of Michal Ben Moshe as General Manager. Michal will be tasked with operational execution of the Company’s business plan, overseeing company goals and curating an agile team to support and enable its growth. Michal will report directly to Kanabo’s CEO, Avihu Tamir. Michal was chosen specifically for the 20 years of leadership experience that she brings having worked as the Senior Director of Finance & Commercial Affairs at S.L.E Ltd., one of the leading providers of logistic and operations in the healthcare ...
Kanabo Group Announces Agreement with PharmaCann Polska for a First-of...
LONDON--(BUSINESS WIRE)-- Kanabo Group Plc, has announced its second key agreement following its hugely successful IPO two weeks ago, with PharmaCann Polska. Under the agreement, PharmaCann and Kanabo will establish a customized production line for Kanabo’s VapePods cartridges. The initial production capability will be approximately 36,000 cartridges a month with the ability to increase production later in the year. The cartridges are an essential part of Kanabo’s VapePod® platform, a medically certified inhalation device that works with patented, precision-targeted formulas. The vaporiser de...
2 directors sold
Two Directors at Spinnaker Opportunities sold 3,200,000 shares at 5.00p. The significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.